Terkko Navigator / Journal of Cachexia, Sarcopenia and Muscle

Impact of prolonged sepsis on neural and muscular components of muscle contractions in a mouse model

Prevalence and factors associated with poor performance in the 5‐chair stand test: findings from the Cognitive Function and Ageing Study II and proposed Newcastle protocol for use in the assessment of sarcopenia

Amelioration of diabetes‐induced inflammation mediated pyroptosis, sarcopenia, and adverse muscle remodelling by bone morphogenetic protein‐7

A comparison of sarcopenia prevalence between former Tokyo 1964 Olympic athletes and general community‐dwelling older adults

Natural ghrelin in advanced cancer patients with cachexia, a case series

Comment on‘The expression landscape of cachexia‐inducing factors in human cancers’ by Freire et al.

The regulatory approval of anamorelin for treatment of cachexia in patients with non‐small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.

Nutrition in the spotlight in cachexia, sarcopenia and muscle: avoiding the wildfire

Weight loss, malnutrition, and cachexia in COVID‐19: facts and numbers

Lean regional muscle volume estimates using explanatory bioelectrical models in healthy subjects and patients with muscle wasting

The role of novel motor unit magnetic resonance imaging to investigate motor unit activity in ageing skeletal muscle

Inflammation‐induced cholestasis in cancer cachexia

The effect of short‐term exercise prehabilitation on skeletal muscle protein synthesis and atrophy during bed rest in older men

Chemotherapy triggers cachexia by deregulating synergetic function of histone‐modifying enzymes

Comment on‘COVID‐19: a major cause of cachexia and sarcopenia’ by Morley et al.

Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort

Biomarkers for cancer cachexia: where do we stand?

Heart and neural crest derivative 2‐induced preservation of sympathetic neurons attenuates sarcopenia with aging

Single‐cell RNA sequencing and lipidomics reveal cell and lipid dynamics of fat infiltration in skeletal muscle

The hypothalamic–pituitary–gonadal axis controls muscle stem cell senescence through autophagosome clearance

Comment on‘Weight loss in heart failure is associated with increased mortality only in non‐obese patients without diabetes’ by Niedziela et al.

Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models

Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults

TAK1 inhibition improves myoblast differentiation and alleviates fibrosis in a mouse model of Duchenne muscular dystrophy

Ribosome biogenesis and degradation regulate translational capacity during muscle disuse and reloading

Stress test: translational research during COVID‐19 pandemic

ACVR2B antagonism as a countermeasure to multi‐organ perturbations in metastatic colorectal cancer cachexia

Normative values of muscle strength across ages in a‘real world’ population: results from the longevity check‐up 7+ project

Blended home‐based exercise and dietary protein in community‐dwelling older adults: a cluster randomized controlled trial

Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipin

Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis

Corrigendum to Bae et al. J Cachexia Sarcopenia Muscle 11, 1089–1103, 2020. doi: 10.1002/jcsm.12563

Association between anorexia of ageing and sarcopenia among Japanese older adults

Associations of combined genetic and epigenetic scores with muscle size and muscle strength: a pilot study in older women

Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?

Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer‐induced cachexia

High levels of modified ceramides are a defining feature of murine and human cancer cachexia

Brain metabolites in cholinergic and glutamatergic pathways are altered by pancreatic cancer cachexia

Comment on‘The expression landscape of cachexia‐inducing factors in human cancers’ by Freire et al.

The authors reply: Comment on“The expression landscape of cachexia‐inducing factors in human cancers” by Freire et al.

Diverging metabolic programmes and behaviours during states of starvation, protein malnutrition, and cachexia

Differential effects of right and left heart failure on skeletal muscle in rats

Improving rehabilitation in sarcopenia: a randomized‐controlled trial utilizing a muscle‐targeted food for special medical purposes

Fast skeletal muscle troponin activator CK‐2066260 mitigates skeletal muscle weakness independently of the underlying cause

lncMGPF is a novel positive regulator of muscle growth and regeneration

The impact of different diagnostic criteria on the association of sarcopenia with injurious falls in the CLSA

The authors reply: Comment on:“Aldehyde dehydrogenases contribute to skeletal muscle homeostasis in healthy, aging, and Duchenne muscular dystrophy patients” by Etienne et al.

Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients

Validation of a description of sarcopenic obesity defined as excess adiposity and low lean mass relative to adiposity

Characterization of cachexia in the human fibrosarcoma HT‐1080 mouse tumour model